IRIS
LUISETTI, MAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.620
EU - Europa 3.211
AS - Asia 2.400
OC - Oceania 24
AF - Africa 15
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.287
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.594
CN - Cina 2.114
IE - Irlanda 921
UA - Ucraina 771
FI - Finlandia 463
DE - Germania 422
SE - Svezia 247
SG - Singapore 188
GB - Regno Unito 131
IT - Italia 112
FR - Francia 52
BE - Belgio 31
CA - Canada 26
AU - Australia 21
IR - Iran 20
HK - Hong Kong 11
IN - India 11
JP - Giappone 11
NL - Olanda 11
TW - Taiwan 11
RU - Federazione Russa 10
CZ - Repubblica Ceca 9
PK - Pakistan 8
ES - Italia 7
IL - Israele 7
EG - Egitto 6
LT - Lituania 6
BR - Brasile 5
EU - Europa 5
KR - Corea 5
CL - Cile 4
ET - Etiopia 3
HU - Ungheria 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PL - Polonia 3
PT - Portogallo 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
AT - Austria 2
LV - Lettonia 2
NG - Nigeria 2
NO - Norvegia 2
VN - Vietnam 2
AZ - Azerbaigian 1
DK - Danimarca 1
GR - Grecia 1
MY - Malesia 1
PE - Perù 1
RO - Romania 1
SA - Arabia Saudita 1
TM - Turkmenistan 1
ZA - Sudafrica 1
Totale 10.287
Salva come PNG Salva come JPEG
Città #
Jacksonville 954
Chandler 927
Dublin 920
Nanjing 640
Boardman 305
Ashburn 279
Nanchang 230
Princeton 199
Lawrence 192
Shenyang 192
Wilmington 170
Hebei 163
Changsha 153
Beijing 151
Ann Arbor 147
Jiaxing 147
Singapore 126
Medford 101
Hangzhou 98
Helsinki 93
Tianjin 87
Shanghai 68
Woodbridge 51
Milan 38
Norwalk 37
Brussels 31
Falls Church 28
Houston 28
Piscataway 26
Fairfield 25
Kunming 25
New York 25
Washington 25
Verona 23
Seattle 21
Des Moines 20
Dearborn 19
Tappahannock 17
Los Angeles 16
Toronto 11
Pavia 10
Zhengzhou 10
Changchun 9
Jinan 9
Fuzhou 8
Auburn Hills 7
Brisbane 7
Jerusalem 7
Lanzhou 7
Ningbo 7
Orange 7
Taizhou 7
Berlin 6
Tokyo 6
Novara 5
Ottawa 5
Rome 5
San Francisco 5
Teplice 5
Chicago 4
Frankfurt am Main 4
Guangzhou 4
Karachi 4
Munich 4
Naples 4
New Taipei City 4
Pune 4
Santa Clara 4
Sydney 4
Addis Ababa 3
Adelaide 3
Amsterdam 3
Birmingham 3
Boston 3
Budapest 3
Chiayi City 3
Honchō 3
Leawood 3
Lewiston 3
Lisbon 3
London 3
Melbourne 3
Montreal 3
Novokuznetsk 3
Oakville 3
Redwood City 3
Santiago 3
São Paulo 3
Taoyuan District 3
Tomsk 3
Al Mansurah 2
Alexandria 2
Aversa 2
Barcelona 2
Borås 2
Cairo 2
Cernusco sul Naviglio 2
Chennai 2
Corsico 2
Dallas 2
Totale 7.063
Salva come PNG Salva come JPEG
Nome #
American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. 259
Matrix elastin: a promising biomarker for chronic obstructive pulmonary disease. 203
Immune Activation in α-1antitrypsin Deficiency Emphysema: Beyond the Protease/Antiprotease Paradigm. 123
Activation of Oncogenic Pathways in Idiopathic Pulmonary Fibrosis. 92
Separation of closely related peptide substrates of human proteinases by micellar electrokinetic chromatography with anionic and nonionic surfactants. 91
Effects of 3'-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products 90
Familial elevation of serum angiotensin converting enzyme activity. 90
Abnormalities of Esophageal Motor Activity Are Highly Prevalent in Lung Transplanted Patients 86
Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency. 85
Advances in proteomic techniques for biomarker discovery in COPD 85
"The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. 81
A national program for detection of alpha 1-antitrypsin deficiency in Italy. Gruppo I.D.A. 80
Capillary electrophoresis with laser-induced fluorescence detection as a novel sensitive approach for the analysis of desmosines in real samples. 77
Alpha-1 antitrypsin deficiency in Italy: regional differences of the PIS and PIZ deficiency alleles. 77
Inherited alpha1-antitrypsin deficiency: Is the level the key message? 75
alpha 1-antitrypsin TAQ I polymorphism and alpha 1-antichymotrypsin mutations in patients with obstructive pulmonary disease. 73
α₁-Antitrypsin level and pheno/genotypes 73
Studies of MR 889, a new synthetic proteinase inhibitor. 73
Identification and characterisation of eight novel SERPINA1 null mutations. 73
Micellar electrokinetic chromatography for the determination of urinary desmosine and isodesmosine in patients affected by chronic obstructive pulmonary disease 72
Alpha1-antitrypsin in serum determined by capillary isoelectric focusing 72
Alpha1-antitrypsin deficiency - diagnostic testing and disease awareness in Germany and Italy. 72
Factors influencing oxidative imbalance in pulmonary fibrosis: an immunohistochemical study. 70
C reactive protein and alpha1-antitrypsin: relationship between levels and gene variants. 70
A novel pharmacological approach for paraquat poisoning in rat and A549 cell line using ambroxol, a lung surfactant synthesis inducer. 70
Some properties of the alkaline proteinase from Aspergillus melleus. 70
A fast amplification-reverse hybridization assay kit to detect the most frequent deficient variants in the alpha-1-antitrypsin gene. 69
Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency. 68
Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report. 68
Assessment and management of pulmonary alveolar proteinosis in a reference center. 68
Alpha1-antitrypsin deficiency: a report from the 2nd meeting of the Alpha One International Registry, Rapallo (Genoa, Italy), 2001. 67
Study of functional and biochemical indicators of subclinical lung damage in bleomycin-treated patients. 67
Proteinase/proteinase inhibitor imbalance in sputum sol phases from patients with chronic obstructive pulmonary disease. Suggestions for a key role played by antileukoprotease. 67
Micellar electrokinetic chromatography: a convenient alternative to colorimetric and high performance liquid chromatographic detection for monitoring protease activity. 65
Surfactant apoprotein A modulates interleukin-8 and monocyte chemotactic peptide-1 production 64
A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1. 64
HLA markers in sarcoidosis. 63
The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency. 63
MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. 62
Ambroxol and pulmonary toxicity induced by antineoplastic drugs. 62
Alpha-1 antitrypsin deficiency: from Italy to the world. 62
The Rapid FEV(1) Decline in Chronic Obstructive Pulmonary Disease Is Associated with Predominant Emphysema: A Longitudinal Study. 62
Association between markers of emphysema and more severe chronic obstructive pulmonary disease. 61
Call for an international survey on therapeutic lavage for pulmonary alveolar proteinosis. 61
The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? 61
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. 61
HLA and sarcoidosis: new pathogenetic insights. 60
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. 60
On the activity of MR 889, a new synthetic proteinase inhibitor. 60
Proteomic analysis of exhaled breath condensate from single patients with pulmonary emphysema associated to alpha1-antitrypsin deficiency. 60
EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells. 60
Inhibition of human neutrophil elastase by erythromycin andflurythromycin, two macrolide antibiotics. 59
Micellar electrokinetic chromatographic and capillary zone electrophoretic methods for screening urinary biomarkers of human disorders: a critical review of the state-of-the-art. 59
Bioavailability of isoniazid, rifampicin and pyrazinamide (in free combination or fixed-triple formulation) in intermittent antituberculous chemotherapy. 59
A large kindred of pulmonary fibrosis associated with a novel ABCA3 gene variant. 59
The Hermansky-Pudlak syndrome. A case with macrophage-neutrophil alveolitis. 59
Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. 58
Complement receptor 1 gene polymorphisms in sarcoidosis. 58
Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. 57
Interactions of alpha-1-antichymotrypsin, alpha-1-proteinase inhibitor, and alpha-2-macroglobulin with the fungal enzyme, seaprose. 57
HLA Class I, II and III polymorphisms in sarcoidosis. 57
Genetics of idiopathic disseminated bronchiectasis. 57
Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis. 57
Protease-antiprotease imbalance: local evaluation with bronchoalveolar lavage. 57
Activity of different proteases in a complex mixture and 'in vitro' study of their reciprocal interferences by micellar electrokinetic chromatography. 57
Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels. 57
Mechanisms of lung injury in cystic fibrosis. 56
Incomplete expression of epithelial-mesenchymal transition markers in idiopathic pulmonary fibrosis. 56
Lung cancer in young adults. 56
Identification of a novel alpha1-antitrypsin null variant (Q0Cairo). 56
COPD: no gene left unturned 56
In vivo studies of rat alveolar macrophage [corrected] microviscosity: influence of pulmonary surfactant synthesis stimulation. 56
Eosinophilic pleural effusion due to mesalamine. Report of a rare occurrence. 56
Micellar Electrokinetic Chromatography with Laser Induced Detection and liquid chromatography tandem mass-spectrometry-based desmosine assays in urine of patients with Chronic Obstructive Pulmonary Disease: A comparative analysis. 56
In Lysinuric Protein Intolerance system y+L activity is defective in monocytes and in GM-CSF-differentiated macrophages. 55
The cystic fibrosis gene is not likely to be involved in chronic obstructive pulmonary disease. 55
Report of one case of familial sarcoidosis. 55
SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort. 55
Biochemical and functional markers of lung damage after bleomycin treatment. 55
Interactions of P 1507, a new antioxidant agent, with phagocyte functions. 54
Introduction: the history of the Alpha One International Registry (A.I.R.). 54
Genetics of chronic obstructive pulmonary disease and disseminated bronchiectasis. 54
Polymorphism of angiotensin-converting enzyme gene in sarcoidosis. 54
Capillary electrophoresis as a modern tool for determining proteolytic activities in purified specimens and in real samples 54
Sarcoidosis of the thyroid: report of a case and a review of the literature. 53
NOD2/CARD15 gene polymorphisms in idiopathic pulmonary fibrosis. 53
Urinary desmosine excretion in acute exacerbations of COPD: a preliminary report. 53
Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline. 53
A novel method for rapid genotypic identification of alpha 1-antitrypsin variants. 53
[American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency]. 53
High performance capillary electrophoresis in the study of proteinase activity and of markers of lung destruction. 52
Clinical utility gene card for: α-1-antitrypsin deficiency. 52
Pharmacokinetic studies on antituberculosis regimens in humans. I. Absorption and metabolism of the compounds used in the initial intensive phase of the short-course regimens: single administration study. 52
Primary lung adenocarcinoma: characteristics by smoking habit and sex. 52
Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics. 52
A Global Survey on Whole Lung Lavage in Pulmonary Alveolar Proteinosis 52
Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates. 51
Mapping the activities of secretory leukoprotease inhibitor. 51
Bronchoalveolar lavage fluid composition in alveolar proteinosis. Early changes after therapeutic lavage. 51
Validation of a rapid, simple method to measure alpha1-antitrypsin in human dried blood spots. 51
Totale 6.661
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.800
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020516 0 0 0 0 0 0 18 175 15 186 120 2
2020/20211.415 179 141 42 152 3 182 11 220 38 215 191 41
2021/2022727 18 5 5 16 17 26 22 60 49 10 126 373
2022/20232.658 284 184 19 225 319 276 0 153 1.061 22 71 44
2023/2024955 102 180 43 67 109 199 14 50 8 68 73 42
2024/2025642 80 225 70 121 51 89 6 0 0 0 0 0
Totale 10.367